GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Yield10 Bioscience Inc (FRA:M6X) » Definitions » Debt-to-Asset

Yield10 Bioscience (FRA:M6X) Debt-to-Asset : 0.71 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Yield10 Bioscience Debt-to-Asset?

Yield10 Bioscience's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1.55 Mil. Yield10 Bioscience's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1.24 Mil. Yield10 Bioscience's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was €3.90 Mil. Yield10 Bioscience's debt to asset for the quarter that ended in Mar. 2024 was 0.71.


Yield10 Bioscience Debt-to-Asset Historical Data

The historical data trend for Yield10 Bioscience's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yield10 Bioscience Debt-to-Asset Chart

Yield10 Bioscience Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.26 0.16 0.34 0.82

Yield10 Bioscience Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.60 0.56 0.82 0.71

Competitive Comparison of Yield10 Bioscience's Debt-to-Asset

For the Agricultural Inputs subindustry, Yield10 Bioscience's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yield10 Bioscience's Debt-to-Asset Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Yield10 Bioscience's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Yield10 Bioscience's Debt-to-Asset falls into.



Yield10 Bioscience Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Yield10 Bioscience's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Yield10 Bioscience's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yield10 Bioscience  (FRA:M6X) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Yield10 Bioscience Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Yield10 Bioscience's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Yield10 Bioscience (FRA:M6X) Business Description

Traded in Other Exchanges
Address
19 Presidential Way, Woburn, MA, USA, 01801
Yield10 Bioscience Inc is an agricultural bioscience company. It focuses on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. The company uses two proprietary advanced biotechnology trait gene discovery platforms to improve fundamental crop yield through enhanced photosynthetic carbon capture and increased carbon utilization efficiency to increase seed yield. Having developed various crops, such as Camelina, canola, soybean, and corn, the firm concentrates to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter.

Yield10 Bioscience (FRA:M6X) Headlines

No Headlines